Dynatronics Corporation (DYNT)
USD 0.11
(1.92%)
USD 0.11
(1.92%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 5.59 Million USD | -24.44% |
| 2023 | 7.4 Million USD | -38.67% |
| 2022 | 12.07 Million USD | 84.97% |
| 2021 | 6.52 Million USD | -22.05% |
| 2020 | 8.37 Million USD | -27.38% |
| 2019 | 11.52 Million USD | 4.92% |
| 2018 | 10.98 Million USD | 48.53% |
| 2017 | 7.39 Million USD | 48.03% |
| 2016 | 4.99 Million USD | -7.83% |
| 2015 | 5.42 Million USD | -11.95% |
| 2014 | 6.15 Million USD | -3.9% |
| 2013 | 6.4 Million USD | 5.07% |
| 2012 | 6.09 Million USD | 7.98% |
| 2011 | 5.64 Million USD | -2.06% |
| 2010 | 5.76 Million USD | -6.98% |
| 2009 | 6.19 Million USD | -1.33% |
| 2008 | 6.28 Million USD | 18.24% |
| 2007 | 5.31 Million USD | 6.64% |
| 2006 | 4.98 Million USD | 5.74% |
| 2005 | 4.71 Million USD | 0.53% |
| 2004 | 4.68 Million USD | 0.93% |
| 2003 | 4.64 Million USD | 21.05% |
| 2002 | 3.83 Million USD | -19.16% |
| 2001 | 4.74 Million USD | 17.52% |
| 2000 | 4.03 Million USD | -10.25% |
| 1999 | 4.5 Million USD | 66.67% |
| 1998 | 2.7 Million USD | 22.73% |
| 1997 | 2.2 Million USD | 37.5% |
| 1996 | 1.6 Million USD | -11.11% |
| 1995 | 1.8 Million USD | 0.0% |
| 1994 | 1.8 Million USD | 28.57% |
| 1993 | 1.4 Million USD | 7.69% |
| 1992 | 1.3 Million USD | 0.0% |
| 1991 | 1.3 Million USD | 0.0% |
| 1990 | 1.3 Million USD | 30.0% |
| 1989 | 1 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | 5.59 Million USD | -9.54% |
| 2024 Q1 | 6.83 Million USD | -7.63% |
| 2024 Q3 | 6.18 Million USD | -8.43% |
| 2024 Q2 | 6.75 Million USD | -1.24% |
| 2023 FY | 7.4 Million USD | -38.67% |
| 2023 Q1 | 11.89 Million USD | -1.44% |
| 2023 Q4 | 7.4 Million USD | -23.7% |
| 2023 Q3 | 9.7 Million USD | -9.71% |
| 2023 Q2 | 10.74 Million USD | -9.68% |
| 2022 Q1 | 7.18 Million USD | 10.15% |
| 2022 Q3 | 11.63 Million USD | 24.74% |
| 2022 Q2 | 9.32 Million USD | 29.71% |
| 2022 FY | 12.07 Million USD | 84.97% |
| 2022 Q4 | 12.07 Million USD | 3.78% |
| 2021 Q2 | 6.14 Million USD | -0.45% |
| 2021 FY | 6.52 Million USD | -22.05% |
| 2021 Q1 | 6.16 Million USD | -26.32% |
| 2021 Q3 | 6.85 Million USD | 11.58% |
| 2021 Q4 | 6.52 Million USD | -4.76% |
| 2020 Q2 | 11.38 Million USD | 2.28% |
| 2020 Q1 | 11.12 Million USD | -3.45% |
| 2020 Q3 | 11.32 Million USD | -0.54% |
| 2020 Q4 | 8.37 Million USD | -26.06% |
| 2020 FY | 8.37 Million USD | -27.38% |
| 2019 Q3 | 11.21 Million USD | 7.51% |
| 2019 Q4 | 11.52 Million USD | 2.75% |
| 2019 FY | 11.52 Million USD | 4.92% |
| 2019 Q1 | 10.52 Million USD | -4.22% |
| 2019 Q2 | 10.43 Million USD | -0.84% |
| 2018 Q4 | 10.98 Million USD | -11.31% |
| 2018 FY | 10.98 Million USD | 48.53% |
| 2018 Q1 | 7.15 Million USD | -3.29% |
| 2018 Q3 | 12.38 Million USD | 6.76% |
| 2018 Q2 | 11.6 Million USD | 62.21% |
| 2017 Q4 | 7.39 Million USD | 27.91% |
| 2017 FY | 7.39 Million USD | 48.03% |
| 2017 Q1 | 5.28 Million USD | 5.76% |
| 2017 Q2 | 5.58 Million USD | 5.66% |
| 2017 Q3 | 5.78 Million USD | 3.56% |
| 2016 Q4 | 4.99 Million USD | -6.91% |
| 2016 FY | 4.99 Million USD | -7.83% |
| 2016 Q3 | 5.36 Million USD | -1.88% |
| 2016 Q2 | 5.47 Million USD | 0.1% |
| 2016 Q1 | 5.46 Million USD | 0.81% |
| 2015 Q3 | 6.14 Million USD | 2.77% |
| 2015 Q1 | 6.02 Million USD | -2.21% |
| 2015 Q2 | 5.98 Million USD | -0.68% |
| 2015 FY | 5.42 Million USD | -11.95% |
| 2015 Q4 | 5.42 Million USD | -11.79% |
| 2014 Q1 | 6.25 Million USD | -2.38% |
| 2014 Q4 | 6.15 Million USD | -1.27% |
| 2014 Q2 | 6.56 Million USD | 5.0% |
| 2014 Q3 | 6.23 Million USD | -5.04% |
| 2014 FY | 6.15 Million USD | -3.9% |
| 2013 Q2 | 6.09 Million USD | 0.03% |
| 2013 Q4 | 6.4 Million USD | 3.56% |
| 2013 Q3 | 6.18 Million USD | 1.56% |
| 2013 FY | 6.4 Million USD | 5.07% |
| 2013 Q1 | 6.09 Million USD | -0.13% |
| 2012 Q1 | 5.78 Million USD | 2.5% |
| 2012 Q3 | 6.11 Million USD | 4.87% |
| 2012 FY | 6.09 Million USD | 7.98% |
| 2012 Q4 | 6.09 Million USD | -0.31% |
| 2012 Q2 | 5.83 Million USD | 0.76% |
| 2011 FY | 5.64 Million USD | -2.06% |
| 2011 Q4 | 5.64 Million USD | 1.77% |
| 2011 Q3 | 5.54 Million USD | -4.03% |
| 2011 Q2 | 5.78 Million USD | 1.11% |
| 2011 Q1 | 5.71 Million USD | -0.83% |
| 2010 Q1 | 6.31 Million USD | 1.83% |
| 2010 FY | 5.76 Million USD | -6.98% |
| 2010 Q4 | 5.76 Million USD | 0.56% |
| 2010 Q3 | 5.73 Million USD | -3.97% |
| 2010 Q2 | 5.97 Million USD | -5.41% |
| 2009 FY | 6.19 Million USD | -1.33% |
| 2009 Q1 | 6.49 Million USD | 3.32% |
| 2009 Q4 | 6.19 Million USD | -5.64% |
| 2009 Q2 | 7.03 Million USD | 8.43% |
| 2009 Q3 | 6.56 Million USD | -6.67% |
| 2008 Q2 | 6.51 Million USD | -2.18% |
| 2008 Q3 | 6.95 Million USD | 6.68% |
| 2008 FY | 6.28 Million USD | 18.24% |
| 2008 Q4 | 6.28 Million USD | -9.63% |
| 2008 Q1 | 6.66 Million USD | 25.39% |
| 2007 Q1 | 5.14 Million USD | 3.21% |
| 2007 FY | 5.31 Million USD | 6.64% |
| 2007 Q4 | 5.31 Million USD | 6.04% |
| 2007 Q3 | 5.01 Million USD | 9.01% |
| 2007 Q2 | 4.59 Million USD | -10.61% |
| 2006 FY | 4.98 Million USD | 5.74% |
| 2006 Q1 | 4.57 Million USD | -2.91% |
| 2006 Q2 | 4.76 Million USD | 4.07% |
| 2006 Q3 | 5.11 Million USD | 7.45% |
| 2006 Q4 | 4.98 Million USD | -2.61% |
| 2005 Q4 | 4.71 Million USD | 1.41% |
| 2005 FY | 4.71 Million USD | 0.53% |
| 2005 Q1 | 4.52 Million USD | -3.52% |
| 2005 Q2 | 4.54 Million USD | 0.54% |
| 2005 Q3 | 4.64 Million USD | 2.2% |
| 2004 Q3 | 4.75 Million USD | 9.58% |
| 2004 Q2 | 4.33 Million USD | -0.88% |
| 2004 Q1 | 4.37 Million USD | -5.83% |
| 2004 Q4 | 4.68 Million USD | -1.32% |
| 2004 FY | 4.68 Million USD | 0.93% |
| 2003 FY | 4.64 Million USD | 21.05% |
| 2003 Q1 | 3.91 Million USD | 2.07% |
| 2003 Q3 | 4.24 Million USD | 3.89% |
| 2003 Q2 | 4.08 Million USD | 4.33% |
| 2003 Q4 | 4.64 Million USD | 9.43% |
| 2002 Q2 | 4.54 Million USD | -4.48% |
| 2002 FY | 3.83 Million USD | -19.16% |
| 2002 Q4 | 3.83 Million USD | -11.63% |
| 2002 Q3 | 4.34 Million USD | -4.48% |
| 2002 Q1 | 4.75 Million USD | 0.26% |
| 2001 Q3 | 4.36 Million USD | 17.95% |
| 2001 FY | 4.74 Million USD | 17.52% |
| 2001 Q1 | 4.12 Million USD | 2.13% |
| 2001 Q2 | 3.69 Million USD | -10.34% |
| 2001 Q4 | 4.74 Million USD | 8.81% |
| 2000 FY | 4.03 Million USD | -10.25% |
| 2000 Q2 | 4.3 Million USD | -2.27% |
| 2000 Q3 | 4.32 Million USD | 0.57% |
| 2000 Q4 | 4.03 Million USD | -6.61% |
| 2000 Q1 | 4.4 Million USD | -2.22% |
| 1999 Q1 | 4.2 Million USD | 55.56% |
| 1999 Q3 | 4.6 Million USD | 2.22% |
| 1999 Q4 | 4.5 Million USD | -2.17% |
| 1999 Q2 | 4.5 Million USD | 7.14% |
| 1999 FY | 4.5 Million USD | 66.67% |
| 1998 Q2 | 2.6 Million USD | 18.18% |
| 1998 Q3 | 2.9 Million USD | 11.54% |
| 1998 Q4 | 2.7 Million USD | -6.9% |
| 1998 FY | 2.7 Million USD | 22.73% |
| 1998 Q1 | 2.2 Million USD | 0.0% |
| 1997 Q2 | 1.6 Million USD | -5.88% |
| 1997 Q4 | 2.2 Million USD | 15.79% |
| 1997 FY | 2.2 Million USD | 37.5% |
| 1997 Q1 | 1.7 Million USD | 6.25% |
| 1997 Q3 | 1.9 Million USD | 18.75% |
| 1996 Q3 | 1.5 Million USD | -6.25% |
| 1996 FY | 1.6 Million USD | -11.11% |
| 1996 Q1 | 1.9 Million USD | 5.56% |
| 1996 Q2 | 1.6 Million USD | -15.79% |
| 1996 Q4 | 1.6 Million USD | 6.67% |
| 1995 Q1 | 1.8 Million USD | 0.0% |
| 1995 FY | 1.8 Million USD | 0.0% |
| 1995 Q4 | 1.8 Million USD | 0.0% |
| 1995 Q3 | 1.8 Million USD | 0.0% |
| 1995 Q2 | 1.8 Million USD | 0.0% |
| 1994 Q3 | 1.7 Million USD | 6.25% |
| 1994 Q1 | 1.5 Million USD | 7.14% |
| 1994 Q2 | 1.6 Million USD | 6.67% |
| 1994 Q4 | 1.8 Million USD | 5.88% |
| 1994 FY | 1.8 Million USD | 28.57% |
| 1993 FY | 1.4 Million USD | 7.69% |
| 1993 Q3 | 1.3 Million USD | 0.0% |
| 1993 Q1 | 1.2 Million USD | -7.69% |
| 1993 Q2 | 1.3 Million USD | 8.33% |
| 1993 Q4 | 1.4 Million USD | 7.69% |
| 1992 Q4 | 1.3 Million USD | 8.33% |
| 1992 Q2 | 1.2 Million USD | 0.0% |
| 1992 FY | 1.3 Million USD | 0.0% |
| 1992 Q1 | 1.2 Million USD | -7.69% |
| 1992 Q3 | 1.2 Million USD | 0.0% |
| 1991 FY | 1.3 Million USD | 0.0% |
| 1991 Q2 | 1.3 Million USD | 0.0% |
| 1991 Q1 | 1.3 Million USD | 0.0% |
| 1991 Q3 | 1.3 Million USD | 0.0% |
| 1991 Q4 | 1.3 Million USD | 0.0% |
| 1990 Q3 | 1.2 Million USD | 0.0% |
| 1990 FY | 1.3 Million USD | 30.0% |
| 1990 Q4 | 1.3 Million USD | 8.33% |
| 1989 Q4 | 1 Million USD | 0.0% |
| 1989 FY | 1 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -69.002% |
| BrainsWay Ltd. | 3.71 Million USD | -50.497% |
| Cerus Corporation | 39.86 Million USD | 85.969% |
| Envoy Medical, Inc. | 1.4 Million USD | -298.431% |
| electroCore, Inc. | 2.16 Million USD | -158.98% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -1124.064% |
| IceCure Medical Ltd | 2.27 Million USD | -145.889% |
| Inogen, Inc. | 21.84 Million USD | 74.387% |
| OrthoPediatrics Corp. | 105.85 Million USD | 94.715% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -1912.221% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -559397300.0% |
| MaxCyte, Inc. | 12.22 Million USD | 54.256% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -223.972% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -3476.252% |
| Orthofix Medical Inc. | 222.16 Million USD | 97.482% |
| PAVmed Inc | 1.01 Million USD | -450.047% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 71.975% |
| RxSight, Inc. | 17.42 Million USD | 67.889% |
| Sight Sciences, Inc. | 7.84 Million USD | 28.73% |
| SI-BONE, Inc. | 20.24 Million USD | 72.374% |
| TELA Bio, Inc. | 13.16 Million USD | 57.499% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 80.872% |
| Vivos Therapeutics, Inc. | 1.00 USD | -559397300.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -30.761% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -2332.163% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -137.435% |
| CVRx, Inc. | 10.98 Million USD | 49.067% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -1334.073% |
| Bioventus Inc. | 91.33 Million USD | 93.875% |
| Venus Concept Inc. | 28.67 Million USD | 80.492% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -119.803% |
| LivaNova PLC | 147.88 Million USD | 96.217% |
| 908 Devices Inc. | 14.93 Million USD | 62.552% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 95.912% |
| Nemaura Medical Inc. | 1.75 Million USD | -218.772% |
| NeuroPace, Inc. | 11.21 Million USD | 50.116% |
| LENSAR, Inc. | 15.68 Million USD | 64.345% |
| Apyx Medical Corporation | 9.92 Million USD | 43.626% |
| Cutera, Inc. | 72.1 Million USD | 92.241% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -109.277% |
| BioSig Technologies, Inc. | -103 Thousand USD | 5531.043% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 87.94% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 29.289% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 98.564% |
| Axonics, Inc. | 79.94 Million USD | 93.002% |
| Outset Medical, Inc. | 49.21 Million USD | 88.634% |
| IRIDEX Corporation | 9.9 Million USD | 43.529% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 85.929% |
| IRadimed Corporation | 12.82 Million USD | 56.369% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -639.944% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -2014.868% |
| Telesis Bio, Inc. | 4.02 Million USD | -38.981% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -21.494% |
| Varex Imaging Corporation | 277.5 Million USD | 97.984% |
| Quipt Home Medical Corp. | 18.32 Million USD | 69.475% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 66.589% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -49.532% |
| Semler Scientific, Inc. | 445 Thousand USD | -1157.073% |
| InMode Ltd. | 45.09 Million USD | 87.595% |
| Bruker Corporation | 968.3 Million USD | 99.422% |
| Cytosorbents Corporation | 3.68 Million USD | -52.005% |
| DexCom, Inc. | 559.6 Million USD | 99.0% |
| Align Technology, Inc. | 296.9 Million USD | 98.116% |
| Viveve Medical, Inc. | 1.47 Million USD | -280.025% |
| ZimVie Inc. | 79.6 Million USD | 92.972% |
| Movano Inc. | 1.51 Million USD | -269.727% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 90.811% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -3476.252% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 96.458% |
| Profound Medical Corp. | 6.95 Million USD | 19.549% |
| Insulet Corporation | 402.6 Million USD | 98.611% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 62.302% |
| iCAD, Inc. | 917 Thousand USD | -510.03% |
| Nuwellis, Inc. | 1.99 Million USD | -180.119% |
| Biotricity, Inc. | 1.87 Million USD | -197.646% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 59.966% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -165.621% |
| PAVmed Inc. | 1.01 Million USD | -450.047% |
| BIOLASE, Inc. | 11.43 Million USD | 51.072% |
| Beyond Air, Inc. | 2.12 Million USD | -162.998% |
| FONAR Corporation | 2.71 Million USD | -106.006% |
| AxoGen, Inc. | 23.02 Million USD | 75.7% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 75.168% |
| Inari Medical, Inc. | 42.9 Million USD | 86.96% |
| UFP Technologies, Inc. | 70.19 Million USD | 92.03% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -789.091% |
| Tenon Medical, Inc. | 554 Thousand USD | -909.743% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -236.03% |
| AdaptHealth Corp. | 113.64 Million USD | 95.078% |
| Sintx Technologies, Inc. | 888 Thousand USD | -529.952% |
| NanoVibronix, Inc. | 2.73 Million USD | -104.757% |
| Quanterix Corporation | 22.36 Million USD | 74.988% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 62.323% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 90.13% |
| TransMedics Group, Inc. | 44.23 Million USD | 87.354% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 1.044% |
| NeuroMetrix, Inc. | 1.55 Million USD | -258.72% |
| Hyperfine, Inc. | 6.58 Million USD | 15.011% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 93.002% |
| Biomerica, Inc. | 2.37 Million USD | -135.437% |
| Bone Biologics Corporation | -328.84 Thousand USD | 1801.103% |
| AVITA Medical, Inc. | 3.12 Million USD | -79.213% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 81.276% |